Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZVRA Zevra Therapeutics

休市中 12-20 15:59:59 EST

8.49

-0.05

-0.59%

盘后8.72

+0.23+2.71%

19:23 EST

最高8.83	最低8.34	成交量254.33万
今开8.48	昨收8.54	日振幅5.70%
总市值4.53亿	流通市值3.66亿	总股本5,338万
成交额2,165万	换手率5.90%	流通股本4,308万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZVRA","market":"US","secType":"STK","nameCN":"Zevra Therapeutics","latestPrice":8.49,"timestamp":1734728399999,"preClose":8.54,"halted":0,"volume":2543275,"hourTrading":{"tag":"盘后","latestPrice":8.72,"preClose":8.49,"latestTime":"19:23 EST","volume":382339,"amount":3246513.52,"timestamp":1734740637227},"delay":0,"floatShares":43084075,"shares":53375932,"eps":-2.106653,"marketStatus":"休市中","marketStatusCode":7,"change":-0.05,"latestTime":"12-20 15:59:59 EST","open":8.475,"high":8.83,"low":8.343,"amount":21646762.166575,"amplitude":0.057026,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.106653,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1429156800000,"adjPreClose":8.54,"preHourTrading":{"tag":"盘前","latestPrice":8.42,"preClose":8.54,"latestTime":"09:29 EST","volume":5516,"amount":46646.947592,"timestamp":1734704999999},"postHourTrading":{"tag":"盘后","latestPrice":8.72,"preClose":8.49,"latestTime":"19:23 EST","volume":382339,"amount":3246513.52,"timestamp":1734740637227},"volumeRatio":5.287389545124784,"impliedVol":0.1446,"impliedVolPercentile":0.0397},"requestUrl":"/m/hq/s/ZVRA","defaultTab":"news","newsList":[{"id":"2485294101","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485294101?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:47","pubTimestamp":1732297662,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时47分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014742971a8271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014742971a8271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ZVRA"],"gpt_icon":0},{"id":"2484677092","title":"Zevra Therapeutics, Inc.2024财年第三财季实现净利润-33.23百万美元，同比减少136.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677092?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945627,"startTime":"0","endTime":"0","summary":"11月19日，Zevra Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-33.23百万美元，同比减少136.51%；其中营业收入为3.70百万美元，同比增加27.59%，每股基本收益为-0.70美元。从资产负债表来看，Zevra Therapeutics, Inc.总负债1.22亿美元，其中短期债务540000.00美元，资产负债比为1.58，流动比率为2.89。机构评级：截至2024年11月19日，当前有7家机构对Zevra Therapeutics, Inc.目标价做出预测，其中目标均价为20.14美元，其中最低目标价为15.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000036a2435260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000036a2435260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVRA"],"gpt_icon":0},{"id":"2483385833","title":"Zevra Therapeutics, Inc.盘中异动 急速上涨5.08%报9.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385833?lang=zh_cn&edition=full","pubTime":"2024-11-15 02:15","pubTimestamp":1731608114,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日02时15分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.08%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115021514a2384cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115021514a2384cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2483884503","title":"Zevra Therapeutics, Inc.盘中异动 快速跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884503?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:30","pubTimestamp":1731508245,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时30分，Zevra Therapeutics, Inc.股票出现异动，股价急速下跌5.83%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322304698e42584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322304698e42584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ZVRA"],"gpt_icon":0},{"id":"2482792466","title":"Zevra Therapeutics Inc 预计每股亏损42美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482792466","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482792466?lang=zh_cn&edition=full","pubTime":"2024-11-09 08:14","pubTimestamp":1731111249,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics Inc 预计每股亏损42美分 - 财报前瞻Zevra Therapeutics Inc ZVRA.OQ ZVRA.O将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。LSEG 分析师对 Zevra Therapeutics Inc 的平均预期是每股亏损 42 美分。华尔街对 Zevra Therapeutics Inc 的 12 个月目标价中位数为 20.50 美元，高于其上次收盘价 9.00 美元。11月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241109:nL4S3MG00M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA"],"gpt_icon":0},{"id":"2473258105","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473258105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473258105?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308262,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZVRA","BK4007","LENZ"],"gpt_icon":0},{"id":"2470110086","title":"Zevra Therapeutics, Inc.盘中异动 股价大跌6.84%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470110086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470110086?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:37","pubTimestamp":1727444237,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速下跌6.84%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ZVRA"],"gpt_icon":0},{"id":"2469493565","title":"美国研究综述-好市多批发、麦凯森、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2469493565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469493565?lang=zh_cn&edition=full","pubTime":"2024-09-24 20:39","pubTimestamp":1727181557,"startTime":"0","endTime":"0","summary":"    路透9月24日 - 华尔街证券分析师周二修改了对几家美国上市公司的评级和目标价，其中包括好市多批发公司、麦凯森和星巴克。要闻  * 好市多批发公司  ：雷蒙德-詹姆斯将其目标价从 880 美元上调至 980 美元             * First Citizens Bancshares   ：Wedbush将其评级从 \"跑赢大盘 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7f827d8c01bff99b769de6f50473596e","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHAK","TW","LU1430594728.SGD","PBH","DAY","LU0417517546.SGD","CL","LU1974910355.USD","KVUE","LU2125909593.SGD","BDTX","IE00BLSP4452.SGD","SG9999001440.SGD","SN","LU2106854487.HKD","BK4106","LU1720051108.HKD","BK4222","REGN","BK4105","PG","LU1923622291.USD","BK4155","OKTA","MCK","BHVN","IE00BZ1G4Q59.USD","LU2237438978.USD","PCOR","EQIX","LW","LU1923622614.USD","SG9999014542.SGD","COST","REPL","ZVRA","SBUX","IDYA","IE00B7SZLL34.SGD","LU1548497426.USD","LU2087625088.SGD","BRZE","LU2125909759.SGD","BFH","LU2360032135.SGD","CHD","LU2125909916.SGD"],"gpt_icon":1},{"id":"2469083437","title":"欧洲研究综述-好市多批发、麦凯森、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2469083437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469083437?lang=zh_cn&edition=full","pubTime":"2024-09-24 15:11","pubTimestamp":1727161860,"startTime":"0","endTime":"0","summary":"    路透9月24日 - 周二，证券分析师修改了对多家欧洲公司的评级和目标价，包括好市多批发公司、麦凯森和星巴克。要闻  * 好市多批发公司  ：雷蒙德-詹姆斯将目标价从880美元上调至980美元 * McKesson Corp   ：贝尔德将目标价从603美元下调至531美元 * 星巴克  ：杰富瑞将其评级从 \"持有 \"下调至 \"表现不佳\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCK","COST","OKTA","BK4183","SHAK","SBUX","BK4504","IE00BWXC8680.SGD","BK4532","LU2125909759.SGD","LU0689626769.HKD","DAY","BFH","LU2125909593.SGD","LW","REPL","BHVN","IE00BZ1G4Q59.USD","LU0965509101.SGD","SN","CRWD","LU0251142724.SGD","BK4539","CL","PBH","IDYA","PG","SG9999001440.SGD","LU2125909916.SGD","BK4581","PCOR","CHD","ZVRA","BRZE","LU0965509010.AUD","KVUE","EQIX","LU1923622291.USD","LU2125154778.USD","LU2242646821.SGD","BK4084","BDTX","IE00B19Z3581.USD","LU2237438978.USD","TW","IE00B894F039.SGD","LU2106854487.HKD","IE00B19Z9Z06.USD"],"gpt_icon":1},{"id":"2469063115","title":"更新版 1-Zevra Therapeutics公司罕见遗传性疾病药物定价高达每月10.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469063115","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469063115?lang=zh_cn&edition=full","pubTime":"2024-09-23 20:45","pubTimestamp":1727095503,"startTime":"0","endTime":"0","summary":"     路透9月23日 - Zevra Therapeutics公司在周一的电话会议上说，该公司用于治疗一种罕见致命遗传性疾病的  药物Miplyffa的批发价为每月4万至10.6万美元，具体取决于用量。该公司表示，根据其扩大准入计划，平均月价格为每月 85,000 美元。据 H.C. Wainwright 分析师估计，该药的平均净定价为每年 50 万至 60 万美元。Miplyffa与米格鲁司他联用，可用于治疗成人和2岁及以上儿童鼻咽癌相关的神经症状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","ZVRA"],"gpt_icon":0},{"id":"2469113033","title":"Zevra Therapeutics公司为遗传性疾病药物定价，每月高达10.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469113033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469113033?lang=zh_cn&edition=full","pubTime":"2024-09-23 20:28","pubTimestamp":1727094520,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月23日 - Zevra Therapeutics公司在周一的电话会议上说，该公司用于治疗一种罕见致命遗传性疾病的药物Miplyffa的批发价为每月4万至10.6万美元，具体取决于用量。美国卫生监管机构周五批准了这种药物，使其成为首个获得批准的治疗 Neimann-Pick 病 C 型的药物--这是一种影响神经系统和其他器官的罕见遗传病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2469967100","title":"BUZZ-Zevra Therapeutics 的罕见遗传病疗法获美国 FDA 批准，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2469967100","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469967100?lang=zh_cn&edition=full","pubTime":"2024-09-21 01:32","pubTimestamp":1726853571,"startTime":"0","endTime":"0","summary":"    9月20日 - ** Zevra Therapeutics   股价上涨1.5%至8.14美元 ** 美国食品和药物管理局批准了  Zevra 治疗 C 型 Neimann-Pick 病的药物，这是第一种治疗这种罕见致命遗传病的药物。** 口服药物Miplyffa与米格鲁司他联合使用，已获准用于治疗2岁及以上患者与NPC相关的神经症状。** ZVRA 计划在 8 到 12 周内在美国上市该药物** H.C. Wainwright 分析师 Oren Livnat 预计，Miplyffa 在美国的最高销售额约为 2.5 亿美元。** 美国食品和药物管理局此前拒绝批准该药，并延长了审查时间** 包括本交易日的走势在内，该股今年累计上涨约 27","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","ZVRA"],"gpt_icon":0},{"id":"2468624839","title":"更新版 1-美国食品和药物管理局批准泽弗拉公司治疗罕见遗传病的方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2468624839","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468624839?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:26","pubTimestamp":1726842385,"startTime":"0","endTime":"0","summary":"     路透9月20日 - 美国食品和药物管理局周五表示，该机构批准了Zevra Therapeutics公司的  治疗罕见致命遗传性疾病的药物，使其成为首个获得批准的治疗该疾病的药物。该 公司多年来一直在努力 将这种药物推向市场， 此前美国卫生监管机构拒绝批准这种药物，并 延长了对该疗法的审查 。这种口服药物被命名为 Miplyffa，现已获准 用于治疗 Neimann-Pick 病 C 型--一种影响神经系统和其他器官的罕见遗传性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"gpt_icon":0},{"id":"2468772629","title":"美国食品和药物管理局批准了泽夫拉的遗传性疾病治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2468772629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468772629?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:10","pubTimestamp":1726841402,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月20日 - 美国食品和药物管理局周五表示，美国食品和药物管理局批准了Zevra Therapeutics公司的  药物用于治疗一种罕见的致命遗传性疾病，这是首个获得批准的治疗该疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"gpt_icon":0},{"id":"2468662514","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468662514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468662514?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:30","pubTimestamp":1726839050,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时30分，Zevra Therapeutics, Inc.股票出现波动，股价快速上涨5.99%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZVRA","LENZ","BK4007"],"gpt_icon":1},{"id":"2468772265","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468772265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468772265?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752667,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分，Zevra Therapeutics, Inc.股票出现异动，股价急速上涨5.24%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1021.42%、333.61%、70.43%，振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Renovaro Inc.，振幅分别为18.34%、11.37%、9.65%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213107a1db3116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213107a1db3116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ZVRA"],"gpt_icon":0},{"id":"2461917887","title":"Zevra Therapeutics, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461917887","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461917887?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:35","pubTimestamp":1724175328,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时35分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.08%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821013529ab5ea72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821013529ab5ea72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ZVRA"],"gpt_icon":0},{"id":"2460717793","title":"Zevra Therapeutics, Inc.2024财年第二财季实现净利润-19.93百万美元，同比减少292.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717793","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717793?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:04","pubTimestamp":1723997077,"startTime":"0","endTime":"0","summary":"8月19日，Zevra Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-19.93百万美元，同比减少292.32%；其中营业收入为4.45百万美元，同比减少47.46%，每股基本收益为-0.48美元。从资产负债表来看，Zevra Therapeutics, Inc.总负债1.12亿美元，其中短期债务596000.00美元，资产负债比为1.29，流动比率为2.00。机构评级：截至2024年8月19日，当前有5家机构对Zevra Therapeutics, Inc.目标价做出预测，其中目标均价为18.00美元，其中最低目标价为11.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190004479f363ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190004479f363ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","LENZ"],"gpt_icon":0},{"id":"2459157170","title":"Zevra Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报7.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459157170","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459157170?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:45","pubTimestamp":1723643136,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时45分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.16%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421453797198b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421453797198b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ZVRA"],"gpt_icon":0},{"id":"2458559594","title":"Zevra Therapeutics, Inc.盘中异动 快速跳水7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458559594","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458559594?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:30","pubTimestamp":1723210224,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时30分，Zevra Therapeutics, Inc.股票出现波动，股价大幅下挫7.17%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.86%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213024aefe258c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213024aefe258c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ZVRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zevra.com","stockEarnings":[{"period":"1week","weight":0.0012},{"period":"1month","weight":-0.0535},{"period":"3month","weight":0.0533},{"period":"6month","weight":0.9472},{"period":"1year","weight":0.7327},{"period":"ytd","weight":0.2962}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zevra Therapeutics, Inc.于2006年10月，在爱荷华州注册成立，并在2014年5月于特拉华州重组。是一家罕见病公司，结合科学、数据和患者需求，为有限或没有治疗选择的疾病创造变革性疗法。该公司拥有多样化的产品组合和候选产品，包括临床前开发项目、临床阶段管道和商业阶段资产。该公司的团队拥有专业的专业知识和成功的记录，在面临复杂的临床和监管挑战的有前途的治疗方面，该公司的方法是平衡科学和数据与患者需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.04085},{"month":2,"riseRate":0.555556,"avgChangeRate":0.053334},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.050529},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.035663},{"month":5,"riseRate":0.5,"avgChangeRate":-0.036976},{"month":6,"riseRate":0.689655,"avgChangeRate":0.030097},{"month":7,"riseRate":0.4,"avgChangeRate":-0.006106},{"month":8,"riseRate":0.6,"avgChangeRate":0.098178},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03249},{"month":10,"riseRate":0.4,"avgChangeRate":-0.102576},{"month":11,"riseRate":0.5,"avgChangeRate":0.068761},{"month":12,"riseRate":0.4,"avgChangeRate":-0.035435}],"exchange":"NASDAQ","name":"Zevra Therapeutics","nameEN":"Zevra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zevra Therapeutics,ZVRA,Zevra Therapeutics股票,Zevra Therapeutics股票老虎,Zevra Therapeutics股票老虎国际,Zevra Therapeutics行情,Zevra Therapeutics股票行情,Zevra Therapeutics股价,Zevra Therapeutics股市,Zevra Therapeutics股票价格,Zevra Therapeutics股票交易,Zevra Therapeutics股票购买,Zevra Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}